ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drugs to Treat Chronic Kidney Disease Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-29X15417
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Drugs to Treat Chronic Kidney Disease Market Research Report 2023
BUY CHAPTERS

Global Drugs to Treat Chronic Kidney Disease Market Research Report 2025

Code: QYRE-Auto-29X15417
Report
May 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Johnson & Johnson
AbbVie
Bayer
Novartis
Sanofi SA
Bristol Myers Squibb Company
Astrazeneca plc
C. H. Boehringer Sohn AG & Co. KG
Amgen Inc
Novo Nordisk A S
Teva Pharmaceutical Industries Ltd
Otsuka Pharmaceutical Co Ltd
Takeda Pharmaceutical Company Limited
Eli Lilly and Company

Drugs to Treat Chronic Kidney Disease Market

The global market for Drugs to Treat Chronic Kidney Disease was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Drugs to Treat Chronic Kidney Disease is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Drugs to Treat Chronic Kidney Disease is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Drugs to Treat Chronic Kidney Disease in Hospital Pharmacies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Drugs to Treat Chronic Kidney Disease include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, C.H. Boehringer Sohn AG & Co. KG, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Drugs to Treat Chronic Kidney Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs to Treat Chronic Kidney Disease.
The Drugs to Treat Chronic Kidney Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs to Treat Chronic Kidney Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs to Treat Chronic Kidney Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Drugs to Treat Chronic Kidney Disease Market Report

Report Metric Details
Report Name Drugs to Treat Chronic Kidney Disease Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, C.H. Boehringer Sohn AG & Co. KG, Amgen Inc., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Takeda Pharmaceutical Company Limited
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Drugs to Treat Chronic Kidney Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Drugs to Treat Chronic Kidney Disease Market report?

Ans: The main players in the Drugs to Treat Chronic Kidney Disease Market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, C.H. Boehringer Sohn AG & Co. KG, Amgen Inc., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Takeda Pharmaceutical Company Limited

What are the Application segmentation covered in the Drugs to Treat Chronic Kidney Disease Market report?

Ans: The Applications covered in the Drugs to Treat Chronic Kidney Disease Market report are Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

What are the Type segmentation covered in the Drugs to Treat Chronic Kidney Disease Market report?

Ans: The Types covered in the Drugs to Treat Chronic Kidney Disease Market report are Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders

Recommended Reports

Chronic Kidney Disease

Renal & Urinary Treatments

Urinary System Therapeutics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Calcimimetics
1.2.3 Vitamin D
1.2.4 Sterols
1.2.5 Potassium Binders
1.2.6 Calcium-Based Phosphate Binders
1.3 Market by Application
1.3.1 Global Drugs to Treat Chronic Kidney Disease Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs to Treat Chronic Kidney Disease Market Perspective (2020-2031)
2.2 Global Drugs to Treat Chronic Kidney Disease Growth Trends by Region
2.2.1 Global Drugs to Treat Chronic Kidney Disease Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drugs to Treat Chronic Kidney Disease Historic Market Size by Region (2020-2025)
2.2.3 Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Region (2026-2031)
2.3 Drugs to Treat Chronic Kidney Disease Market Dynamics
2.3.1 Drugs to Treat Chronic Kidney Disease Industry Trends
2.3.2 Drugs to Treat Chronic Kidney Disease Market Drivers
2.3.3 Drugs to Treat Chronic Kidney Disease Market Challenges
2.3.4 Drugs to Treat Chronic Kidney Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs to Treat Chronic Kidney Disease Players by Revenue
3.1.1 Global Top Drugs to Treat Chronic Kidney Disease Players by Revenue (2020-2025)
3.1.2 Global Drugs to Treat Chronic Kidney Disease Revenue Market Share by Players (2020-2025)
3.2 Global Drugs to Treat Chronic Kidney Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drugs to Treat Chronic Kidney Disease Revenue
3.4 Global Drugs to Treat Chronic Kidney Disease Market Concentration Ratio
3.4.1 Global Drugs to Treat Chronic Kidney Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs to Treat Chronic Kidney Disease Revenue in 2024
3.5 Global Key Players of Drugs to Treat Chronic Kidney Disease Head office and Area Served
3.6 Global Key Players of Drugs to Treat Chronic Kidney Disease, Product and Application
3.7 Global Key Players of Drugs to Treat Chronic Kidney Disease, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs to Treat Chronic Kidney Disease Breakdown Data by Type
4.1 Global Drugs to Treat Chronic Kidney Disease Historic Market Size by Type (2020-2025)
4.2 Global Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Type (2026-2031)
5 Drugs to Treat Chronic Kidney Disease Breakdown Data by Application
5.1 Global Drugs to Treat Chronic Kidney Disease Historic Market Size by Application (2020-2025)
5.2 Global Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drugs to Treat Chronic Kidney Disease Market Size (2020-2031)
6.2 North America Drugs to Treat Chronic Kidney Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drugs to Treat Chronic Kidney Disease Market Size by Country (2020-2025)
6.4 North America Drugs to Treat Chronic Kidney Disease Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drugs to Treat Chronic Kidney Disease Market Size (2020-2031)
7.2 Europe Drugs to Treat Chronic Kidney Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drugs to Treat Chronic Kidney Disease Market Size by Country (2020-2025)
7.4 Europe Drugs to Treat Chronic Kidney Disease Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs to Treat Chronic Kidney Disease Market Size (2020-2031)
8.2 Asia-Pacific Drugs to Treat Chronic Kidney Disease Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drugs to Treat Chronic Kidney Disease Market Size by Region (2020-2025)
8.4 Asia-Pacific Drugs to Treat Chronic Kidney Disease Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drugs to Treat Chronic Kidney Disease Market Size (2020-2031)
9.2 Latin America Drugs to Treat Chronic Kidney Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drugs to Treat Chronic Kidney Disease Market Size by Country (2020-2025)
9.4 Latin America Drugs to Treat Chronic Kidney Disease Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs to Treat Chronic Kidney Disease Market Size (2020-2031)
10.2 Middle East & Africa Drugs to Treat Chronic Kidney Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drugs to Treat Chronic Kidney Disease Market Size by Country (2020-2025)
10.4 Middle East & Africa Drugs to Treat Chronic Kidney Disease Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Drugs to Treat Chronic Kidney Disease Introduction
11.1.4 Pfizer Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
11.1.5 Pfizer Inc. Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Drugs to Treat Chronic Kidney Disease Introduction
11.2.4 Johnson & Johnson Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
11.2.5 Johnson & Johnson Recent Development
11.3 AbbVie Inc.
11.3.1 AbbVie Inc. Company Details
11.3.2 AbbVie Inc. Business Overview
11.3.3 AbbVie Inc. Drugs to Treat Chronic Kidney Disease Introduction
11.3.4 AbbVie Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
11.3.5 AbbVie Inc. Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Details
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Drugs to Treat Chronic Kidney Disease Introduction
11.4.4 Bayer AG Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
11.4.5 Bayer AG Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Drugs to Treat Chronic Kidney Disease Introduction
11.5.4 Novartis AG Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
11.5.5 Novartis AG Recent Development
11.6 Sanofi SA
11.6.1 Sanofi SA Company Details
11.6.2 Sanofi SA Business Overview
11.6.3 Sanofi SA Drugs to Treat Chronic Kidney Disease Introduction
11.6.4 Sanofi SA Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
11.6.5 Sanofi SA Recent Development
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Company Details
11.7.2 Bristol-Myers Squibb Company Business Overview
11.7.3 Bristol-Myers Squibb Company Drugs to Treat Chronic Kidney Disease Introduction
11.7.4 Bristol-Myers Squibb Company Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
11.7.5 Bristol-Myers Squibb Company Recent Development
11.8 AstraZeneca plc
11.8.1 AstraZeneca plc Company Details
11.8.2 AstraZeneca plc Business Overview
11.8.3 AstraZeneca plc Drugs to Treat Chronic Kidney Disease Introduction
11.8.4 AstraZeneca plc Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
11.8.5 AstraZeneca plc Recent Development
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Details
11.9.2 Eli Lilly and Company Business Overview
11.9.3 Eli Lilly and Company Drugs to Treat Chronic Kidney Disease Introduction
11.9.4 Eli Lilly and Company Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
11.9.5 Eli Lilly and Company Recent Development
11.10 C.H. Boehringer Sohn AG & Co. KG
11.10.1 C.H. Boehringer Sohn AG & Co. KG Company Details
11.10.2 C.H. Boehringer Sohn AG & Co. KG Business Overview
11.10.3 C.H. Boehringer Sohn AG & Co. KG Drugs to Treat Chronic Kidney Disease Introduction
11.10.4 C.H. Boehringer Sohn AG & Co. KG Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
11.10.5 C.H. Boehringer Sohn AG & Co. KG Recent Development
11.11 Amgen Inc.
11.11.1 Amgen Inc. Company Details
11.11.2 Amgen Inc. Business Overview
11.11.3 Amgen Inc. Drugs to Treat Chronic Kidney Disease Introduction
11.11.4 Amgen Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
11.11.5 Amgen Inc. Recent Development
11.12 Novo Nordisk A/S
11.12.1 Novo Nordisk A/S Company Details
11.12.2 Novo Nordisk A/S Business Overview
11.12.3 Novo Nordisk A/S Drugs to Treat Chronic Kidney Disease Introduction
11.12.4 Novo Nordisk A/S Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
11.12.5 Novo Nordisk A/S Recent Development
11.13 Teva Pharmaceutical Industries Ltd.
11.13.1 Teva Pharmaceutical Industries Ltd. Company Details
11.13.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.13.3 Teva Pharmaceutical Industries Ltd. Drugs to Treat Chronic Kidney Disease Introduction
11.13.4 Teva Pharmaceutical Industries Ltd. Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
11.13.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.14 Otsuka Pharmaceutical Co. Ltd.
11.14.1 Otsuka Pharmaceutical Co. Ltd. Company Details
11.14.2 Otsuka Pharmaceutical Co. Ltd. Business Overview
11.14.3 Otsuka Pharmaceutical Co. Ltd. Drugs to Treat Chronic Kidney Disease Introduction
11.14.4 Otsuka Pharmaceutical Co. Ltd. Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
11.14.5 Otsuka Pharmaceutical Co. Ltd. Recent Development
11.15 Takeda Pharmaceutical Company Limited
11.15.1 Takeda Pharmaceutical Company Limited Company Details
11.15.2 Takeda Pharmaceutical Company Limited Business Overview
11.15.3 Takeda Pharmaceutical Company Limited Drugs to Treat Chronic Kidney Disease Introduction
11.15.4 Takeda Pharmaceutical Company Limited Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
11.15.5 Takeda Pharmaceutical Company Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Johnson & Johnson
AbbVie
Bayer
Novartis
Sanofi SA
Bristol Myers Squibb Company
Astrazeneca plc
C. H. Boehringer Sohn AG & Co. KG
Amgen Inc
Novo Nordisk A S
Teva Pharmaceutical Industries Ltd
Otsuka Pharmaceutical Co Ltd
Takeda Pharmaceutical Company Limited
Eli Lilly and Company
List of Tables
 Table 1. Global Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Calcimimetics
 Table 3. Key Players of Vitamin D
 Table 4. Key Players of Sterols
 Table 5. Key Players of Potassium Binders
 Table 6. Key Players of Calcium-Based Phosphate Binders
 Table 7. Global Drugs to Treat Chronic Kidney Disease Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Drugs to Treat Chronic Kidney Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Drugs to Treat Chronic Kidney Disease Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Drugs to Treat Chronic Kidney Disease Market Share by Region (2020-2025)
 Table 11. Global Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Drugs to Treat Chronic Kidney Disease Market Share by Region (2026-2031)
 Table 13. Drugs to Treat Chronic Kidney Disease Market Trends
 Table 14. Drugs to Treat Chronic Kidney Disease Market Drivers
 Table 15. Drugs to Treat Chronic Kidney Disease Market Challenges
 Table 16. Drugs to Treat Chronic Kidney Disease Market Restraints
 Table 17. Global Drugs to Treat Chronic Kidney Disease Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Drugs to Treat Chronic Kidney Disease Market Share by Players (2020-2025)
 Table 19. Global Top Drugs to Treat Chronic Kidney Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs to Treat Chronic Kidney Disease as of 2024)
 Table 20. Ranking of Global Top Drugs to Treat Chronic Kidney Disease Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Drugs to Treat Chronic Kidney Disease Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Drugs to Treat Chronic Kidney Disease, Headquarters and Area Served
 Table 23. Global Key Players of Drugs to Treat Chronic Kidney Disease, Product and Application
 Table 24. Global Key Players of Drugs to Treat Chronic Kidney Disease, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Drugs to Treat Chronic Kidney Disease Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Drugs to Treat Chronic Kidney Disease Revenue Market Share by Type (2020-2025)
 Table 28. Global Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Drugs to Treat Chronic Kidney Disease Revenue Market Share by Type (2026-2031)
 Table 30. Global Drugs to Treat Chronic Kidney Disease Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Drugs to Treat Chronic Kidney Disease Revenue Market Share by Application (2020-2025)
 Table 32. Global Drugs to Treat Chronic Kidney Disease Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Drugs to Treat Chronic Kidney Disease Revenue Market Share by Application (2026-2031)
 Table 34. North America Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Drugs to Treat Chronic Kidney Disease Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Drugs to Treat Chronic Kidney Disease Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Drugs to Treat Chronic Kidney Disease Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Drugs to Treat Chronic Kidney Disease Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Drugs to Treat Chronic Kidney Disease Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Drugs to Treat Chronic Kidney Disease Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Drugs to Treat Chronic Kidney Disease Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Drugs to Treat Chronic Kidney Disease Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Drugs to Treat Chronic Kidney Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Drugs to Treat Chronic Kidney Disease Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Drugs to Treat Chronic Kidney Disease Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Pfizer Inc. Company Details
 Table 50. Pfizer Inc. Business Overview
 Table 51. Pfizer Inc. Drugs to Treat Chronic Kidney Disease Product
 Table 52. Pfizer Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025) & (US$ Million)
 Table 53. Pfizer Inc. Recent Development
 Table 54. Johnson & Johnson Company Details
 Table 55. Johnson & Johnson Business Overview
 Table 56. Johnson & Johnson Drugs to Treat Chronic Kidney Disease Product
 Table 57. Johnson & Johnson Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025) & (US$ Million)
 Table 58. Johnson & Johnson Recent Development
 Table 59. AbbVie Inc. Company Details
 Table 60. AbbVie Inc. Business Overview
 Table 61. AbbVie Inc. Drugs to Treat Chronic Kidney Disease Product
 Table 62. AbbVie Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025) & (US$ Million)
 Table 63. AbbVie Inc. Recent Development
 Table 64. Bayer AG Company Details
 Table 65. Bayer AG Business Overview
 Table 66. Bayer AG Drugs to Treat Chronic Kidney Disease Product
 Table 67. Bayer AG Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025) & (US$ Million)
 Table 68. Bayer AG Recent Development
 Table 69. Novartis AG Company Details
 Table 70. Novartis AG Business Overview
 Table 71. Novartis AG Drugs to Treat Chronic Kidney Disease Product
 Table 72. Novartis AG Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025) & (US$ Million)
 Table 73. Novartis AG Recent Development
 Table 74. Sanofi SA Company Details
 Table 75. Sanofi SA Business Overview
 Table 76. Sanofi SA Drugs to Treat Chronic Kidney Disease Product
 Table 77. Sanofi SA Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025) & (US$ Million)
 Table 78. Sanofi SA Recent Development
 Table 79. Bristol-Myers Squibb Company Company Details
 Table 80. Bristol-Myers Squibb Company Business Overview
 Table 81. Bristol-Myers Squibb Company Drugs to Treat Chronic Kidney Disease Product
 Table 82. Bristol-Myers Squibb Company Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025) & (US$ Million)
 Table 83. Bristol-Myers Squibb Company Recent Development
 Table 84. AstraZeneca plc Company Details
 Table 85. AstraZeneca plc Business Overview
 Table 86. AstraZeneca plc Drugs to Treat Chronic Kidney Disease Product
 Table 87. AstraZeneca plc Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025) & (US$ Million)
 Table 88. AstraZeneca plc Recent Development
 Table 89. Eli Lilly and Company Company Details
 Table 90. Eli Lilly and Company Business Overview
 Table 91. Eli Lilly and Company Drugs to Treat Chronic Kidney Disease Product
 Table 92. Eli Lilly and Company Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025) & (US$ Million)
 Table 93. Eli Lilly and Company Recent Development
 Table 94. C.H. Boehringer Sohn AG & Co. KG Company Details
 Table 95. C.H. Boehringer Sohn AG & Co. KG Business Overview
 Table 96. C.H. Boehringer Sohn AG & Co. KG Drugs to Treat Chronic Kidney Disease Product
 Table 97. C.H. Boehringer Sohn AG & Co. KG Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025) & (US$ Million)
 Table 98. C.H. Boehringer Sohn AG & Co. KG Recent Development
 Table 99. Amgen Inc. Company Details
 Table 100. Amgen Inc. Business Overview
 Table 101. Amgen Inc. Drugs to Treat Chronic Kidney Disease Product
 Table 102. Amgen Inc. Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025) & (US$ Million)
 Table 103. Amgen Inc. Recent Development
 Table 104. Novo Nordisk A/S Company Details
 Table 105. Novo Nordisk A/S Business Overview
 Table 106. Novo Nordisk A/S Drugs to Treat Chronic Kidney Disease Product
 Table 107. Novo Nordisk A/S Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025) & (US$ Million)
 Table 108. Novo Nordisk A/S Recent Development
 Table 109. Teva Pharmaceutical Industries Ltd. Company Details
 Table 110. Teva Pharmaceutical Industries Ltd. Business Overview
 Table 111. Teva Pharmaceutical Industries Ltd. Drugs to Treat Chronic Kidney Disease Product
 Table 112. Teva Pharmaceutical Industries Ltd. Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025) & (US$ Million)
 Table 113. Teva Pharmaceutical Industries Ltd. Recent Development
 Table 114. Otsuka Pharmaceutical Co. Ltd. Company Details
 Table 115. Otsuka Pharmaceutical Co. Ltd. Business Overview
 Table 116. Otsuka Pharmaceutical Co. Ltd. Drugs to Treat Chronic Kidney Disease Product
 Table 117. Otsuka Pharmaceutical Co. Ltd. Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025) & (US$ Million)
 Table 118. Otsuka Pharmaceutical Co. Ltd. Recent Development
 Table 119. Takeda Pharmaceutical Company Limited Company Details
 Table 120. Takeda Pharmaceutical Company Limited Business Overview
 Table 121. Takeda Pharmaceutical Company Limited Drugs to Treat Chronic Kidney Disease Product
 Table 122. Takeda Pharmaceutical Company Limited Revenue in Drugs to Treat Chronic Kidney Disease Business (2020-2025) & (US$ Million)
 Table 123. Takeda Pharmaceutical Company Limited Recent Development
 Table 124. Research Programs/Design for This Report
 Table 125. Key Data Information from Secondary Sources
 Table 126. Key Data Information from Primary Sources
 Table 127. Authors List of This Report


List of Figures
 Figure 1. Drugs to Treat Chronic Kidney Disease Picture
 Figure 2. Global Drugs to Treat Chronic Kidney Disease Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Drugs to Treat Chronic Kidney Disease Market Share by Type: 2024 VS 2031
 Figure 4. Calcimimetics Features
 Figure 5. Vitamin D Features
 Figure 6. Sterols Features
 Figure 7. Potassium Binders Features
 Figure 8. Calcium-Based Phosphate Binders Features
 Figure 9. Global Drugs to Treat Chronic Kidney Disease Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Drugs to Treat Chronic Kidney Disease Market Share by Application: 2024 VS 2031
 Figure 11. Hospital Pharmacies Case Studies
 Figure 12. Online Pharmacies Case Studies
 Figure 13. Retail Pharmacies Case Studies
 Figure 14. Drugs to Treat Chronic Kidney Disease Report Years Considered
 Figure 15. Global Drugs to Treat Chronic Kidney Disease Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Drugs to Treat Chronic Kidney Disease Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Drugs to Treat Chronic Kidney Disease Market Share by Region: 2024 VS 2031
 Figure 18. Global Drugs to Treat Chronic Kidney Disease Market Share by Players in 2024
 Figure 19. Global Top Drugs to Treat Chronic Kidney Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs to Treat Chronic Kidney Disease as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Drugs to Treat Chronic Kidney Disease Revenue in 2024
 Figure 21. North America Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Drugs to Treat Chronic Kidney Disease Market Share by Country (2020-2031)
 Figure 23. United States Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Drugs to Treat Chronic Kidney Disease Market Share by Country (2020-2031)
 Figure 27. Germany Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Drugs to Treat Chronic Kidney Disease Market Share by Region (2020-2031)
 Figure 35. China Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Drugs to Treat Chronic Kidney Disease Market Share by Country (2020-2031)
 Figure 43. Mexico Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Drugs to Treat Chronic Kidney Disease Market Share by Country (2020-2031)
 Figure 47. Turkey Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Drugs to Treat Chronic Kidney Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Pfizer Inc. Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
 Figure 51. Johnson & Johnson Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
 Figure 52. AbbVie Inc. Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
 Figure 53. Bayer AG Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
 Figure 54. Novartis AG Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
 Figure 55. Sanofi SA Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
 Figure 56. Bristol-Myers Squibb Company Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
 Figure 57. AstraZeneca plc Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
 Figure 58. Eli Lilly and Company Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
 Figure 59. C.H. Boehringer Sohn AG & Co. KG Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
 Figure 60. Amgen Inc. Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
 Figure 61. Novo Nordisk A/S Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
 Figure 62. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
 Figure 63. Otsuka Pharmaceutical Co. Ltd. Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
 Figure 64. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Drugs to Treat Chronic Kidney Disease Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Chronic Kidney Disease Treatment Market Research Report 2025
Global Chronic Kidney Disease CKD Treatment Market Research Report 2025
Renal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Late Stage Chronic Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Kidney Disease Drugs Market Research Report 2025
Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Renal Disease Treatment Market Research Report 2024
Global Kidney Medicine Market Insights Forecast to 2030
Chronic Kidney Disease CKD Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
End Stage Renal Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Kidney Fibrosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Kidney Fibrosis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Kidney Disease Nutritional Supplement Market Research Report 2024
Global Chronic Disease Treatment Market Research Report 2024
Global Complement Drug for Kidney Disease Market Research Report 2024
Global Renal Therapeutic Market Research Report 2025
Kidney Renal Fibrosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Renal Medical Devices Market Research Report 2024
Rare Kidney Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Polycystic Kidney Disease Treatment Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions